Skip to main content
African Health Sciences logoLink to African Health Sciences
. 2012 Jun;12(2):140–147. doi: 10.4314/ahs.v12i2.10

Prevalence of Microalbuminuria among secondary school children

AN Okpere 1, IC Anochie 1, FU Eke 1
PMCID: PMC3462545  PMID: 23056019

Abstract

Background

Microalbuminuria is an early sign of kidney and cardiovascular damage. Therefore, early detection in asymptomatic individuals may be helpful in preventing deterioration in renal function.

Methods

We carried out a cross-sectional study of 820 secondary school students aged 10 – 19 years from September to November 2008. The urine samples of 615 (75.0%) without overt proteinuria and haematuria were tested for microalbuminuria using the micral test strips. Values of greater than 20mg/L were considered positive.

Results

There were 299 (48.6%) males and 316 (51.4%) females, with a M:F ratio of 1:1.1. The prevalence of microalbuminuria as seen in 214 of the students was 33.2%. It was significantly higher in females (45.3%), obese subjects (35.4%), those with hypertension (70.6%), those with positive family history of hypertension (59.5%), and diabetes mellitus (46.4%). Microalbuminuria was found in 1 of the 2 subjects who had features of DM and in one subject with sickle cell anemia.

Conclusion

The prevalence of microalbuminuria in Nigerian adolescents is high. We recommend routine screening for microalbuminuria in adolescents for early detection and prevention of renal damage.

Keywords: microalbuminuria, obesity, hypertension, children, Nigeria

Introduction

Microalbuminuria is a subclinical condition that is associated with high morbidity and mortality.1,2 It is the excretion of very small amounts of albumin in urine, slightly in excess of 20 microgram per minute (ìg/min).3 Microalbuminuria is an early sign of damage to the kidneys and cardiovascular system.1,4,5 It has been found to be highly prevalent in several disease conditions in adults2,6, as well as in children and adolescents. 7,8,9,10 The major identified causes of microalbuminuria include diabetes mellitus (DM)7,11,12, hypertension1,13, sickle cell anaemia (SCA)9, Human Immunodeficiency Virus (HIV) infection10, and obesity.14

The prevalence of microalbuminuria in the general population is reported to be 10 – 15%.6 In the Netherlands1, microalbuminuria was found in 12.1% of apparently healthy adults in the general population. In the United States of America (USA), Jones et al 15 reported a lower prevalence of 7.8% in the general population of children, adolescents, and adults. In Africa, there is paucity of data on the prevalence of microalbuminuria in the general population of children. In Nigeria, Ibadin et al16 reported a 19% prevalence of microalbuminuria among healthy adolescents and young adult offsprings (aged 10–24 years) of hypertensive parents in Benin City.

In diabetic patients, microalbuminuria predicts the development of overt diabetic nephropathy5,17, while in hypertensive patients, it is associated with cardiovascular events such as myocardial ischaemia and stroke. 1,13 It is also an early sign of sickle cell nephropathy in patients with SCA.9 In non-diabetic and non-hypertensive subjects, presence of microalbuminuria is associated with increased levels of athrogenic factors and an increase in cardiovascular morbidities and mortalities.18

Individuals with microalbuminuria may have a rapid progression to overt proteinuria, progressive deterioration in renal function, and development of end stage renal disease (ESRD) later in life.2,19 For primary prevention of ESRD, nephrologists are focusing on early detection of microalbuminuria in asymptomatic individuals, so that appropriate interventions can be commenced early to prevent further deterioration in renal function.19,20,21

This study was carried out to determine the prevalence of microalbuminuria and factors associated with microalbuminuria in the general population of adolescents, and also to improve on the paucity of data from Africa.

Methods

A cross-sectional study was done over a period of eight weeks, between September 29th to November 10th 2008 in twelve secondary schools in Port Harcourt City, the capital of Rivers State of Nigeria. Rivers State is located in the South-South geo-political zone of Nigeria. It is a major industrial center in Nigeria and the regional headquarters of the petroleum sector. Twelve secondary (eight private and four public) schools and 864 students aged 10 – 19 years were selected using multi-staged sampling technique, from the fifty-two secondary schools in Port Harcourt City. The sample size was calculated from the formula22:

n=Z2(pq)d2

Where n is the desired sample size; Z is the standard normal deviate, usually set at1.96 which corresponds to the 95% confidence level, so that Z2 = 3.8416; p is the prevalence of microalbuminuria; 19.0% was the prevalence of microalbuminuria in healthy adolescents and young adults in a study conducted in Benin City, Nigeria16; therefore p is equal to 0.19; q is 1 − p and d is the degree of accuracy desired, set at 0.04 so that d2 is equal to 0.016. Therefore,

n=Z2(pq)d2

A total of 820 students were however recruited for the study to give allowance for design effect and attrition. The following exclusion criteria were used: students who had been involved in vigorous exercise or competitive sport twelve hours prior to the study, students with fever at the time of study or a history of febrile illness two weeks pior to the study, students with signs and symptoms suggestive of pre-existing renal disease, female students who were menstruating and within one week of cessation of menses at the time of study, those with history of vaginal discharge, and male students with history of urethral discharge.

Ethical clearance was obtained from the Research and Ethics Committee of the University of Port Harcourt Teaching Hospital (UPTH). Permission was also obtained from the Rivers State Ministry of Education, principals of the selected schools, as well as the selected students and their parents/guardians.

The study was carried out on school days in the various schools. For each student, a detailed history was obtained including the bio-data; symptoms such as fever, body swelling, dysuria, polyuria, polydipsia, polyphagia, weight loss and bone pains; medical history to identify causes of microalbuminuria as well as family history of diabetes mellitus or hypertension. The social class of each subject was determined using the social classification described by Oyedeji23 based on the profession and educational level of both parents. A brief physical examination checking for facial or leg oedema, temperature, weight, height, and blood pressure was performed in an enclosed room or the school's clinic where available. The Body Mass Index (BMI) for each subject was calculated as weight (kg)/height (m2). The nutritional status of the subjects was calculated using the BMI percentile charts for age and sex according to the United States Centers for Disease Control and Prevention 2000 growth charts24. A subject was classified as obese when the BMI was equal to or greater than the 95th percentile. Those whose blood pressures were elevated on the first day where re-checked the next day. Hypertension was defined as blood pressure greater than or equal to the 95th percentile for age, sex and height.25

After the clinical examination, each subject voided about ten milliliters (mls) of spot urine into a 20mls universal container (A) which had been previously labeled with the subject's study number. Five milliliters of the urine was then withdrawn using a 5mls syringe into a second universal bottle (B) which had also been previously labeled with the subject's study number.

A dipstick urinalysis was performed on the urine sample on container A to test for protein, leucocytes, blood, nitrite, and glucose using the Combi-ScreenR .10SL manufactured by Macherey Nagel MN, Germany with Lot number 56704. The urinalysis was considered positive when any of the components was positive. Positive nitrite and leukocyte esterase were considered suggestive of urinary tract infection; presence of glycosuria in the presence of polyuria, polyphagia or polydipsia was suggestive of diabetes mellitus. However, the diagnosis of diabetes mellitus was not confirmed with a fasting blood sugar level because the investigators were not permitted to collect blood samples from the students. Also, in line with this, the students were not screened for HIV infection. The results were entered into a proforma attached to the questionnaire

The urine samples in container B of those subjects who were negative for proteinuria and blood on dipstick urinalysis were tested immediately for microalbuminuria using the Micral-test strips manufactured by Roche, USA with Lot number 28989833. There were four colour blocks on the micral test strip vial (0, 20, 50, 100 milligram per liter (mg/L)) reflecting the categories of albumin concentrations. A reading of 20mg/L and above was considered positive for microalbuminuria.

All adolescents with abnormal urine finding, obesity and hypertension were referred to the pediatric nephrology/endocrine unit of the University of Port Harcourt Teaching Hospital (UPTH) for further evaluation.

Data analysis

Data from the study wereanalysed using the computer programme Epidemiological Information Software (EPI - INFO) version 6.04 and the Statistical Package for Social Sciences (SPSS) version 15.0. The Chi- square analysis, student's t test and one-way analysis of variance (ANOVA) were used where appropriate to test proportions. Pearson's correlation was used to measure association. In all cases, a p value of < 0.05 was regarded as statistically significant.

Results

Of the 820 students, 194 (23.7%) had overt proteinuria and 11 (1.3%) had haematuria on dipstick urinalysis and were excluded from further analysis. The remaining 615 (75.0%) students formed the study population. Table 1 shows the characteristics of the study population. There were 299 (48.6%) males and 316 (51.4%) females giving, a male to female (M:F) ratio of 1:1.1. They were aged 10–19 years (mean 13.6 ± 2.2 years). Majority (66.2%) of the subjects were aged 10–14 years. The mean age of the male subjects was 14.0 ± 2.3 years, while that of the females was 13.2 ± 2.0 years. The difference was statistically significant (t = 4.040; p = 0.000). Majority of the students were in private school and belonged to social class I as shown in table 1.

Table 1.

Characteristics of the study population

Parameter Number %
Sex
Male 299 48.6
Female 316 51.4
Age group
10–14years 407 66.2
15–17years 177 28.8
18–19years 31 5.0
School type
Private 366 59.5
Public 249 40.5
Social class
I 234 38.1
II 71 11.5
III 122 19.8
IV 179 29.1

Prevalence of microalbuminuria

Out of the 615 students analysed, 214 subjects had microalbuminuria, giving a prevalence of microalbuminuria as 33.2%. They comprised 61 (29.9%) males and 143 (70.1%) females. The proportional prevalence of microalbuminuria was significantly higher in females (chi sqaure = 42.803; p = 0.000). Table 2 shows the characteristics of the subjects with and without microalbuminuria. Microalbuminuria was present in all the different age groups.

Table 2.

Characteristics of the study subjects with and without Microalbuminuria

Parameter Microalbuminuria Total (%) p value

Positive (%) Negative (%)
Age group
10–14years 137 (33.7) 270 (66.3) 407 (100)
15–17years 66 (37.3) 111 (62.7) 177 (100) 0.001
18–19years 1 (3.2) 30 (96.8) 31 (100)
Sex
Male 61 (20.4) 238 (79.6) 299 (100)
Female 143 (45.3) 173 (54.7) 316 (100)
School type
Private 116 (31.7) 250 (68.3) 366 (100)
Public 88 (35.3) 161 (64.7) 249 (100)
Social class
I 71 (30.3) 163 (69.7) 234 (100)
II 27 (38.0) 44 (62.0) 71 (100) 0.645
III 45 (36.9) 77 (63.1) 122 (100)
IV 58 (32.4) 121 (67.6) 179 (100)
V 3 (33.3) 6 (66.7) 9 (100)

The mean age of the subjects with microalbuminuria was 13.6 ± 1.9 years, while that of those without microalbuminuria was 13.6 ± 2.3 years; the difference was not statistically significant (t = −0.464 ; p = 0.643). The proportional prevalence of microalbuminuria was significantly higher in the age group 15–17 years and lowest after the age of 17 years (chi sqaure = 13.937; p = 0.001). The proportional prevalence of microalbuminuria was higher in students in the public school. This was however not statistically significant (chi sqaure = 0.889 ; p = 0.346). Furthermore, social class did not affect the prevalence of microalbuminuria (chi sqaure = 2.408 ; p = 0.661). The mean weight and BMI of subjects with microalbuminuria (48.6 ±1.3kg and 19.7 ±3.7 respectively) were higher than those without microalbuminuria (47.1± 11.1 and 19.2 ± 3.4 respectively). However, the difference was not statistically significant (t = 1.500; p = 0.134 and t = 1.544; p = 0.123 respectively).

Factors associated with microalbuminuria in adolescents

Obesity

Obesity was identified in 65 (10.6%) of the subjects. Of these, 23 (35.4%) had microalbuminuria. The proportional prevalence of microalbuminuria was significantly higher in the obese subjects compared to those without obesity (chi square = 0.16; p = 0.669), as shown in table 3.

Table 3.

Factors associated with Microalbuminuria adolescents

Parameter Microalbuminuria Total (%) p value OR (95% CI)

Positive(%) Negative(%)
Obesity 23 (35.4) 42 (64.6) 65 (100) 0.689 1.116 (0.651 – 1.913)
Non-obese 181 (32.9) 369 (67.1) 550 (100)
Hypertension 12 (70.6) 5 (29.4) 17 (100) 0.001 0.197 (0.680 – 0.567)
Normal BP 192 (32.1) 406 (67.9) 550 (100)
Possible DM 1 (50) 1 (50) 2 (100) 0.554
No features of DM 203 (33.1) 401 (66.9) 613 (100)
Fx of Hypertension 25 (59.5) 17 (40.5) 42 (100) 0 3.237 (1.705 – 6.145)
No Fx of Hypertension 179 (31.2) 394 (68.8) 573 (100)
Fx of DM 26 (46.4) 30 (53.6) 56(100) 0.027 1.855 (1.065 – 3.230)
No Fx of DM 178 (31.8) 381 (68.2) 559 (100)

OR = Odds Ratio; CI = Confidence Interval; DM = Diabetes Mellitus; Fx = Family history

Hypertension

Blood pressure was elevated in 17 (2.8%) subjects. Twelve (70.6%) of the subjects with hypertension had microalbuminuria. The proportional prevalence was significantly higher in those with elevated blood pressure compared to those with normal blood pressure (chi square = 11.042; p = 0.001).

Possible diabetes mellitus

Two (0.3%) subjects had features of diabetes mellitus. One of these (50%) had microalbuminuria. The difference was however not statistically significant (chi square = 0.256 ; p = 0.613).

Sickle Cell Anaemia (SCA)

The haemoglobin genetope of only 11 (1.8%) students were obtained. Two (18.2%) of these had genotype SS while the remaining 9 (81.8%) students had genotype AA. Microalbuminuria was present in 1 (50%) of the 2 (18.2%) students with SS genotype.

Family history of hypertension

Family history of hypertension was obtained from 42 (6.8%) of the subjects of which 25 (59.5%) had microalbuminuria. There was significantly higher prevalence of microalbuminuria in subjects with positive family history of hypertension compared to those without family history of hypertension (chi square2 = 14.122; p = 0.000) as shown in table 3. Only 1 (2.4%) of the students with a family history of hypertension had high blood pressure.

Family history of diabetes mellitus

Family history of diabetes mellitus was obtained from 56 (9.1%) subjects, and 26 (46.4%) had microalbuminuria.. There was significantly higher prevalence of microalbuminuria in subjects with positive family history of diabetes mellitus, compared to those without family history of diabetes mellitus (chi square = 4.885; p = 0.027 respectively). However, there was no significant difference in the subjects whether the hypertension, or diabetes mellitus existed in the mother, father or other relations (chi square = 0.502; p = 0.809 and chi square = 4.374; p = 0.224 respectively).

However, when all the associated factors of microalbuminuria were subjected to further logistic regression analysis, only hypertension (adjusted odds ratio (OR) = 5.393; 95% confidence interval [CI] = 1.791 − 16.236) and diabetes mellitus (adjusted OR =5.390; CI=0.310 − 0.939) were significantly associated with microalbuminuria as shown in table 4.

Table 4.

Crude and adjusted odds ratios for Microalbuminuria in adolescents

Factor Crude
OR (95% CI)
Adjusted
OR (95% CI)
Obesity 1.116 (0.651 – 1.913) 0.859 (0.474 – 1.555)
Hypertension 0.197 (0.680 – 0.567) 0.177 (0.570 – 0.552)
Possible DM 2.020 (0.126 – 32.455 0.931 (0.555 – 15.776)
Fx of Hypertension 3.237 (1.705 – 6.145) 1.374 (0.736 – 2.566)
Fx of Dm 1.855 (1.065 – 3.230 3.098 (1.548 – 6.198)

DM = Diabetes Mellitus; OR = Odds ratio; CI = Confidence interval.

Discussion

The study noted a higher prevalence of microalbuminuria at 33.2% compared to the 19% reported by Ibadin et al16 in Benin City, Nigeria and the 7.8% reported by Jones et al15 in the United States of America. The lower prevalence reported by Ibadin et al16 may be due to the exclusion of subjects with obesity and hypertension from the study while that reported by Jones et al15 may be due to the larger sample size and the wide variation in the ages of the study population. In contrast, the prevalence of microalbuminuria in this study is much lower than the 61.0% prevalence reported by Unuigbe et al26 among medical students in Benin City. The higher prevalence reported by Unuigbe et al 26 may be attributed to the fact that the subjects were older (25–35 years) and hence more likely to have microalbuminuria.27,28

The finding of a significantly higher gender-specific prevalence of microalbuminuria in females (45.3%) compared to males (20.4%) is similar to the findings recorded by Jones el al15 in the USA, who reported a gender specific prevalence of 9.7% in females and 6.1% in males in the general population. The higher prevalence of microalbuminuria in females has also been reported among children with sickle cell anaemia (SCA) by Dharnidharka et al13 in the USA. The cause of the gender disparity in favour of females cannot be readily explained. In contrast, Ibadin et al16 reported a higher prevalence in males (20.8%) compared to females (16.7%). The authors suggested that the gender disparity may be attributed to under-representation of females in hypertensive disease in the general population.

In this study, the age-specific prevalence of microalbuminuria was significantly higher in subjects aged 15–17 years, compared to the younger subjects aged 10–14years. This is similar to the findings reported by Unuigbe et al26 in Benin City, Jones el al15 in the USA and by Marsenic et al29 and McBurney at al30 among childern with sickle cell amaenia in the USA. They reported a positive correlation between microalbuminuria and age. The present study therefore supports previous reports that microalbuminuria increases with increasing age.

The higher prevalence of microalbuminuria in obese subjects compared to their counterparts who had normal weight is similar to the findings recorded by Unuigbe et al.26 They reported a positive correlation between microalbuminuria and body mass index (BMI). Similarly, Diercks et al1 in the PREVEND study conducted in Australia and Valensi et al14 in the USA reported a strong association between obesity and microalbuminuria. Obesity is strongly associated with microalbuminuria.31 It is a well documented risk marker for progressive renal function loss in patients with renal disease.31 With the rising global epidemic of obesity in children and adolescents32,33 and ESRD34, the exact role of obesity in renal disease requires further evaluation. In contrast, Hwang et al27 reported an inverse relationship between microalbuminuria and BMI. They reported a higher prevalence of microalbuminuria in non-obese subjects. The authors could not explain the reason for the negative correlation between microalbuminuria and obesity.

The high prevalence of microalbunimuria in subjects with elevated blood pressure is similar to the findings reported by Unuigbe et al26, Jones et al15, and Diercks et al1 in the general population. They reported a positive correlation between microalbuminuria and hypertension in the study subjects. In the present study, the 59.5% prevalence of hypertension in subjects with family history of hypertension was significantly higher than 31.2% prevalence in those without family history of hypertension. In consonance with this, Ibadin et al16 reported a 19.0% prevalence of microalbuminuria in off-springs of hypertensive parents and a lower 8.0% prevalence in the control group who were subjects of normotensive parents. Unuigbe et al26 also reported a positive correlation between microalbuminuria and family history of hypertension in Benin City. The findings of this study may suggest that children with family history of hypertension have increased predisposition to microalbuminuria. Some authors have reported that microalbuminuria is linked to the pathogenesis of hypertension and serves as a predictor of hypertension in normotensive individuals.16,26,35 While Ibadin et al16 reported a higher prevalence in subjects with paternal history of hypertension, in the present study, the prevalence of microalbuminuria did not vary significantly whether the hypertension existed in the mother or father.

The 46.4% of microalbuminuria in subjects with family history of diabetes mellitus (DM) is much higher than the 31.8% prevalence in those without family history of DM. This is similar to the findings recorded by Unuigbe et al26 who reported a higher prevalence of microalbuminuria in subjects with family history of diabetes. Although none of the subjects in the present study were known diabetic patients, microalbuminuria was present in one of the subjects with polyuria, polyphagia and glycosuria. Microalbuminuria is a chronic microvascular complication of DM.5 It predicts the development of incipient nephropathy in diabetic subjects.5,17 The findings of this present study may suggest that microalbuminuria probably predates clinical diagnosis of DM and where there is a family history of diabetes, it can be used as a tool to identify those at risk of developing DM and nephropathy later in life.

Sickle cell anaemia is a well documented risk factor for microalbuminuria.9 However, the exact relationship between microalbuminuria and sickle cell anaemia could not be established in the present study as the haemoglobin genotype of all the subjects was not known. However, one of the two known sickle cell anaemia patients had microalbuminuria. The subject was normotensive and did not have family history of hypertension and diabetes mellitus.

The limitations of this study were the inability to identify and exclude students with orthostatic proteinuria and physiologic proteinuria due to routine physical activity such as trekking to school.

Conclusion

The prevalence of microalbuminuria in adolescents aged 10 to 19 years is high. The proportional prevalence was significantly higher in female subjects compared to the male subjects. The factors associated with microalbuminuria were obesity, hypertension, family history of hypertension and diabetes mellitus, and sickle cell anaemia. We recommend routine screening of adolescents for microalbuminuria for early detection and prevention of renal damage.

References

  • 1.Diercks GF, Van Boven AJ, Hillege HL, Janssen WM, Kors JA, de Jong PE, et al. Microalbuminuria is independently associated with ischaemic electrocardiographic abnormalities in a large non-diabetic population. The PREVEND Study. Eur Heart J. 2000;21:1922–1927. doi: 10.1053/euhj.2000.2248. [DOI] [PubMed] [Google Scholar]
  • 2.Perkins BA, Ficociello LH, Ostrander BE, Silva KH, Weinberg J, Warram JH, et al. Microalbuminuria and the risk for early progressive renal functions decline in type 1 diabetes. J Am Soc Nephrol. 2007;18:1353–1361. doi: 10.1681/ASN.2006080872. [DOI] [PubMed] [Google Scholar]
  • 3.Herbert D, Fish AJ. Renal manifestation of systemic disorder. In: Posltethwaite RJ, editor. Clinical Paediatric Nephrology. Bristol: Wright; 1986. p. 146. [Google Scholar]
  • 4.Verhave JC, Gansevoort RT, Hillege HL, Bakker SJ, de Zeeuw D, de Jong PE. An elevated urinary albumin excretion predicts de novo development of renal function impairment in the general population. Kidney Int. 2004;66(suppl 92):18–21. doi: 10.1111/j.1523-1755.2004.09205.x. for the PREVEND study group. [DOI] [PubMed] [Google Scholar]
  • 5.Feld LG. Diabetic Nephropathy. In: Barret MT, Aver ED, Harmon WE, editors. Paediatric Nephrology. 4th ed. Maryland: Lippincolt Williams and Wilkins; 1999. pp. 633–640. [Google Scholar]
  • 6.Mogensen CE, Keane WF, Bennett PH, Jerums G, Parving HH, Passa P, et al. Prevention of diabetic renal disease with special reference to microalbuminuria. Lancet. 1995;346:1080–1084. doi: 10.1016/s0140-6736(95)91747-0. [DOI] [PubMed] [Google Scholar]
  • 7.Jones CA, Leese GP, Kerr S, et al. Development and progression of microalbuminuria in a clinic sample of patients with insulin dependent diabetes mellitus. Arch Dis Child. 1998;78:518–523. doi: 10.1136/adc.78.6.518. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Stone ML, Craig ME, Chan AK, et al. Natural history and risk factors for microalbuminuria in adolescents with type 1 diabetes. Diabetes Care. 2006;29:2072–2077. doi: 10.2337/dc06-0239. (2006) [DOI] [PubMed] [Google Scholar]
  • 9.Dharnidharka VR, Dabbagh S, Atiyeh B, et al. Prevalence of microalbuminuira in children with sickle cell disease. Pediatr Nephrol. 1998;12:475–478. doi: 10.1007/s004670050491. [DOI] [PubMed] [Google Scholar]
  • 10.Leroy B, Pressac M, Bensman A, et al. Renal status in Human immunodeficiency (HIV) infected children: a prospective study. Int Conf AIDS. 1992;8:B232. [Google Scholar]
  • 11.Schultz CJ, Konopelska-Bahu T, Dalton RN, et al. Microalbuminuria prevalence varies with age, sex and puberty in children with type 1 diabetes followed from diagnosis in a longitudinal study: Oxford Regional Prospective Study Group. Diabetes Care. 1999;22:495–502. doi: 10.2337/diacare.22.3.495. [DOI] [PubMed] [Google Scholar]
  • 12.Donaghue KC, Fairfield JM, Chan A, et al. Diabetes complications screening in 937 children and adolescents. J Pediatr Endocrinol Metab. 1999;12:18–192. doi: 10.1515/jpem.1999.12.2.185. [DOI] [PubMed] [Google Scholar]
  • 13.Pedrinelli R. Microalbuminuria in hypertension. Nephrol. 1996;73:499–505. doi: 10.1159/000189131. [DOI] [PubMed] [Google Scholar]
  • 14.Valensi P, Assayag M, Busby M, et al. Microalbuminuria in obese patients with or without hypertension. Int J Obes. 1996;20:574–579. [PubMed] [Google Scholar]
  • 15.Jones CA, Francis ME, Eberhardt MS, et al. Microalbuminuria in the US population: Third National Health and Nutrition Examination Survey (NHANES III) Am J Kidney Dis. 2002;39:445–459. doi: 10.1053/ajkd.2002.31388. [DOI] [PubMed] [Google Scholar]
  • 16.Ibadin MO, Onunu A, Unuigbe E, et al. Microalbuminuria in adolescents/ young adult offsprings of hypertensive Nigerian adults - a preliminary report. Nig J Clin Pract. 2004;7:60–64. [Google Scholar]
  • 17.Mogensen CE, Christensen CK, Vittinghus E. The stages in diabetic renal disease with emphasis in the stage of incipient diabetic nephropathy. Diabetes. 1983;32:64–78. doi: 10.2337/diab.32.2.s64. [DOI] [PubMed] [Google Scholar]
  • 18.Hillege HL, Fidler V, Diercks GF, et al. Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population. Circulation. 2002;106:1777–1782. doi: 10.1161/01.cir.0000031732.78052.81. [DOI] [PubMed] [Google Scholar]
  • 19.Correa-Rotter R, Naicker S, Katz IJ, et al. Demographic and epidemiologic transition in the developing world. Role of albuminuria in the early diagnosis and prevention of renal and cardiovascular disease. Kidney Int. 2004;92(suppl 66):32–37. doi: 10.1111/j.1523-1755.2004.09208.x. [DOI] [PubMed] [Google Scholar]
  • 20.De Jong PE, Brenner BM. From secondary to primary prevention of progressive renal disease: the case for screening for albuminuria. Kidney Int. 2004;92(suppl 66):109–118. doi: 10.1111/j.1523-1755.2004.66001.x. suppl. [DOI] [PubMed] [Google Scholar]
  • 21.Ruggenenti P, Perna A, Gherardi G, et al. Renoproctective properties of ACE inhibition in non-diabetic nephropathies with nonnephrotic proteinuria. Lancet. 1999;354:359–364. doi: 10.1016/S0140-6736(98)10363-X. [DOI] [PubMed] [Google Scholar]
  • 22.Araoye MO. Research Methodology with Statistics for Health and Social Sciences. Illorin, Nigeria: Nathadex; 2003. Subjects Selection; pp. 115–122. [Google Scholar]
  • 23.Oyedeji GA. Socio-economic and cultural background of hospitalized children in Ilesha. Nig J Paed. 1985;12:111–117. [Google Scholar]
  • 24.United States National Center for Health Statistics in collaboration for the National Center for Chronic disease Prevention and Health promotion. 2000. [Google Scholar]
  • 25.Report of the second task force on blood pressure control in children. Pediatrics. 1987;79:1–25. [PubMed] [Google Scholar]
  • 26.Unuigbe EI, Ighoroje AD, Imariagbe FA, et al. Screening for microalbuminuria amongst medical students in University of Benin: a pilot study. JMBR. 2002;1:29–33. [Google Scholar]
  • 27.Hwang KK, Scott LT, Chifamba J, et al. Microalbuminuria in urban Zimbabwean Women. J Hum Hypertens. 2000;14:587–593. doi: 10.1038/sj.jhh.1001069. [DOI] [PubMed] [Google Scholar]
  • 28.Winocour PH. Microalbuminuria and associated cardiovascular risk factors in the community. Artherosclerosis. 1992;93:71–81. doi: 10.1016/0021-9150(92)90201-q. [DOI] [PubMed] [Google Scholar]
  • 29.Marsenic O, Couloures KG, Wiley JM. Proteinuria in children with sickle cell disease. Nephrol Dial Transplant. 2008;23:715–720. doi: 10.1093/ndt/gfm858. [DOI] [PubMed] [Google Scholar]
  • 30.McBurney PG, Hanevold CD, Hernandez CM, et al. Risk factors for microalbuminuria in children with sickle cell anemia. J Pediatr Hematol Oncol. 2002;24:473–477. doi: 10.1097/00043426-200208000-00013. [DOI] [PubMed] [Google Scholar]
  • 31.De Jong PE, Verhave JC, Pinto-Sietsma SJ, et al. Obesity and target organ damage: The kidney. Int J Obes Relat Metab Disord. 2002;(suppl 26):21–24. doi: 10.1038/sj.ijo.0802213. [DOI] [PubMed] [Google Scholar]
  • 32.Ogden CL, Carroll MD, Curtin LR, et al. Prevalence of overweight and obesity in the United States, 1999–2004. JAMA. 2006;295:1549–1555. doi: 10.1001/jama.295.13.1549. [DOI] [PubMed] [Google Scholar]
  • 33.Ogden CL, Kuczmarski RJ, Flegal KM. Centers for Disease Control and Prevention 2000 growth charts for the United States: Improvements to the 1977 National Center for Health statistics version. Pediatrics. 2002;109:45–60. doi: 10.1542/peds.109.1.45. [DOI] [PubMed] [Google Scholar]
  • 34.US Renal Data System, author. Excerpts from the USRDS 2001 Annual Data Report: Atlas of end-stage renal disease in the United States. Am J Kidney Dis. 2001;(suppl):38–48. [Google Scholar]
  • 35.Nishigo M, Nakagawa H, Morikawa Y, et al. Microalbuminuria in non-diabetic Japanese men. Am J Hypertens. 1999;12:16–20. doi: 10.1016/s0895-7061(98)00181-2. [DOI] [PubMed] [Google Scholar]

Articles from African Health Sciences are provided here courtesy of Makerere University Medical School

RESOURCES